Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Loading...
Community
/
United States
/
Pharmaceuticals & Biotech
/
ImmunityBio
Create a narrative
ImmunityBio Community
NasdaqGS:IBRX Community
0
Narratives
written by author
0
Comments
on narratives written by author
45
Fair Values set
on narratives written by author
Community Investing Ideas
ImmunityBio
Popular
Undervalued
Overvalued
There are no community narratives available.
Your Valuation for
IBRX
IBRX
ImmunityBio
Your Fair Value
US$
Current Price
US$2.33
28.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-598m
551m
2015
2018
2021
2024
2025
2027
2030
Revenue US$550.6m
Earnings US$116.1m
Advanced
Set Fair Value